Fiserv Inc. Common Stock vs NeoGenomics Inc. Common Stock — how do they compare? Fiserv Inc. Common Stock trades at $46.18 (market cap $24.81B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: Fiserv Inc. Common Stock is far larger — about 11.6× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| FISV | NEO | |
|---|---|---|
Market Cap | $24.81B | $2.14B |
Volume | 4,091,234 | 2,228,400 |
Sector | Technology | Health |
52-Week High | $126.54 | $19.91 |
52-Week Low | $44.36 | $7.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $52.60B | $2.44B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →